Evidence map›Paper›PMID 35684157›Full record

Trial reportNutrients2022

Effects of Five Amino Acids (Serine, Alanine, Glutamate, Aspartate, and Tyrosine) on Mental Health in Healthy Office Workers: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial.

Kentaro Umeda, Daichi Shindo, Shinji Somekawa, Shinobu Nishitani, Wataru Sato, Sakiko Toyoda, Sachise Karakawa, Mika Kawasaki, Tomoyuki Mine, Katsuya Suzuki

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Kentaro UmedaInstitute of Food Sciences and Technologies, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.ORCID 0000-0001-7761-4703
Daichi ShindoInstitute of Food Sciences and Technologies, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.
Shinji SomekawaInstitute of Food Sciences and Technologies, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.
Shinobu NishitaniInstitute of Food Sciences and Technologies, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.
Wataru SatoResearch Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.ORCID 0000-0003-1502-3515
Sakiko ToyodaResearch Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.
Sachise KarakawaResearch Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.ORCID 0000-0003-1272-3348
Mika KawasakiResearch Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.
Tomoyuki MineResearch & Business Planning Department, Ajinomoto Co., Inc., Tokyo 104-8315, Japan.
Katsuya SuzukiInstitute of Food Sciences and Technologies, Ajinomoto Co., Inc., Kawasaki 210-8681, Japan.
Ajinomoto (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe importance of maintaining good mental health with overall well-being has recently drawn attention from various spheres of academics and the working population. Amino acid intake has been reported to reduce depression symptoms and other mental health problems. However, the effectiveness of amino acid intake (i.e., single or combined) remains unknown. In this study, we assessed a combination of five amino acids (serine, alanine, glutamate, aspartate, and tyrosine; SAGAT) reported to regulate mental health.

methodsA randomized, double-blind, placebo-controlled exploratory trial was conducted. Participants, aged between 20 and 65 years with fatigue sensation, were randomized to receive either SAGAT or the placebo and ingested them for four weeks. A transient mental work was loaded at day 0 and after four weeks of intervention. As the primary outcomes, the fatigue sensation was assessed. The mood status, cognitive function, work efficiency, and blood marker were also measured as secondary outcomes.

resultsThe number of participants analyzed for the efficacy evaluation were 20 in SAGAT and 22 in the placebo. There were no significant differences in the primary outcomes. However, as the secondary outcomes, the SAGAT group showed a significant improvement in motivation and cognitive function in the recovery period after mental work loaded in a four-week intervention compared to the placebo.

conclusionThe current findings suggest that SAGAT contributes to maintaining proper motivation and cognitive function. CLINICAL

trial registrationUniversity Hospital Medical Information Network Clinical Trial Registry (ID: UMIN 000041221).

Indexed as

Amino AcidsMental HealthOccupational HealthAdultAgedAlanineAspartic AcidDouble-Blind MethodGlutamic AcidHumansMental FatigueMiddle AgedSerineTreatment OutcomeTyrosineYoung AdultAlanineAmino AcidsAspartic AcidGlutamic AcidSerineTyrosineamino acidscognitive functionmental healthmotivation

Identifiers

PMID35684157
PMCPMC9183184
OpenAlexW4281678921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.